AAAAAA
Results:
1-14
|
Results: 14
Authors:
Caronia, S
Bassendine, MF
Barry, R
Mills, P
Naoumov, NV
Fox, R
Lowes, J
Hollanders, D
Murray-Lyon, L
Irving, WL
Goldin, RD
Foster, GR
Citation: S. Caronia et al., Interferon plus amantadine versus interferon alone in the treatment of naive patients with chronic hepatitis C: a UK multicentre study, J HEPATOL, 35(4), 2001, pp. 512-516
Authors:
Naoumov, NV
Lopes, AR
Burra, P
Caccamo, L
Iemmolo, RM
de Man, RA
Bassendine, M
O'Grady, JG
Portmann, BC
Anschuetz, G
Barrett, CA
Williams, R
Atkins, M
Citation: Nv. Naoumov et al., Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantation, J HEPATOL, 34(6), 2001, pp. 888-894
Authors:
Ijaz, S
Torre, F
Tedder, RS
Williams, R
Naoumov, NV
Citation: S. Ijaz et al., Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients, J MED VIROL, 63(3), 2001, pp. 210-216
Authors:
Bjoro, K
Petrova, EP
Thomas, MG
Froland, SS
Williams, R
Naoumov, NV
Citation: K. Bjoro et al., TT virus infection in patients with primary hypogammaglobulinaemia: Natural history and relationship to liver disease in the immunocompromised host, SC J GASTR, 36(9), 2001, pp. 987-993
Authors:
Naoumov, NV
Citation: Nv. Naoumov, TT virus - highly prevalent, but still in search of a disease, J HEPATOL, 33(1), 2000, pp. 157-159
Authors:
Marinos, G
Rossol, S
Carucci, P
Wong, PYN
Donaldson, P
Hussain, MJ
Vergani, D
Portmann, BC
Williams, R
Naoumov, NV
Citation: G. Marinos et al., Immunopathogenesis of hepatitis B virus recurrence after liver transplantation, TRANSPLANT, 69(4), 2000, pp. 559-568
Authors:
Maini, MK
Boni, C
Lee, CK
Larrubia, JR
Reignat, S
Ogg, GS
King, AS
Herberg, J
Gilson, R
Alisa, A
Williams, R
Vergani, D
Naoumov, NV
Ferrari, C
Bertoletti, A
Citation: Mk. Maini et al., The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection, J EXP MED, 191(8), 2000, pp. 1269-1280
Authors:
Cramp, ME
Rossol, S
Chokshi, S
Carucci, P
Williams, R
Naoumov, NV
Citation: Me. Cramp et al., Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C, GASTROENTY, 118(2), 2000, pp. 346-355
Authors:
Janssen, HLA
Gerken, G
Carreno, V
Marcellin, P
Naoumov, NV
Craxi, A
Ring-Larsen, H
Kitis, G
van Hattum, J
de Vries, RA
Michielsen, PP
ten Kate, FJW
Hop, WCJ
Heijtink, RA
Honkoop, P
Schalm, SW
Citation: Hla. Janssen et al., Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment, HEPATOLOGY, 30(1), 1999, pp. 238-243
Authors:
Naoumov, NV
Citation: Nv. Naoumov, Hepatitis C virus infection in Eastern Europe, J HEPATOL, 31, 1999, pp. 84-87
Authors:
Torre, F
Wong, PYN
Macartney, M
Williams, R
Naoumov, NV
Citation: F. Torre et al., Evolution of wild-type and precore mutant HBV infection after liver transplantation, J MED VIROL, 59(1), 1999, pp. 5-13
Authors:
Gane, EJ
Maertens, G
Ducatteeuw, A
Qian, KP
Lau, JYN
Jones, H
Davies, E
Naoumov, NV
Williams, R
Citation: Ej. Gane et al., Antibodies to hepatitis C virus envelope proteins correlate with hepatitisC viraemia after liver transplantation, TRANSPLANT, 67(1), 1999, pp. 78-84
Authors:
Cramp, ME
Carucci, P
Rossol, S
Chokshi, S
Maertens, G
Williams, R
Naoumov, NV
Citation: Me. Cramp et al., Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia, GUT, 44(3), 1999, pp. 424-429
Authors:
Naoumov, NV
Citation: Nv. Naoumov, Hepatitis C virus-specific CD4C T cells: Do they help or damage?, GASTROENTY, 117(4), 1999, pp. 1012-1014
Risultati:
1-14
|